This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) slipped 0.97% to $716.22 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.61% to 4,462.21 and the Dow Jones Industrial Average rising 1.45% to 34,911.20. This was the stock's second consecutive day of losses. Regeneron Pharmaceuticals Inc. closed $31.20 short of its 52-week high ($747.42), which the company achieved on April 8th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 3.05% to $183.08, Novartis AG ADR (NOVN.EB) fell 0.72% to $91.60, and Amgen Inc. (AMGN) rose 0.57% to $253.37. Trading volume (467,979) remained 228,141 below its 50-day average volume of 696,120.
Data source: Dow Jones Market Data, FactSet. Data compiled April 19, 2022.
(END) Dow Jones Newswires
April 19, 2022 17:18 ET (21:18 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.